IMARC Group’s report titled "Immunoglobulin Market Report by Product (IgG, IgA, IgM, IgE, IgD), Application (Hypogammaglobulinemia, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Immunodeficiency Disease, Myasthenia Gravis, and Others), Mode of Delivery (Intravenous Mode of Delivery, Subcutaneous Mode of Delivery), and Region 2024-2032". offers a comprehensive analysis of the industry, which comprises insights on the global immunoglobulin market share. The global market size reached US$ 15.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 24.9 Billion by 2032, exhibiting a growth rate (CAGR) of 5.1% during 2024-2032.
Grab a sample PDF of this report: https://www.imarcgroup.com/immunoglobulin-market/requestsample
Factors Affecting the Growth of the Immunoglobulin Industry:
- Increasing Prevalence of Immunodeficiency and Autoimmune Disorders:
The rising prevalence of immunodeficiency and autoimmune disorders among the masses across the globe is propelling the market growth. Conditions like primary immunodeficiency diseases (PID), chronic inflammatory demyelinating polyneuropathy (CIDP), and autoimmune diseases necessitate regular administration of immunoglobulin therapies to manage symptoms and enhance patient quality of life. These therapies are essential for increasing the immune system's function, particularly in individuals with compromised immune responses. In addition, the growing awareness among individuals about the diagnosis of these conditions is positively influencing the market.
- Advancements in Biotechnology and Manufacturing Processes:
Innovations in biotechnology and manufacturing processes have revolutionized the immunoglobulin market. Enhanced purification techniques and innovative production methods assist in improving the safety and efficacy of immunoglobulin products. These advancements allow for higher yields and purer products, reducing the risk of adverse reactions. Innovations, such as subcutaneous immunoglobulins (SCIG), provide more convenient and patient-friendly treatment options, allowing for home-based administration and improved adherence to therapy. The ongoing research and development (R&D) efforts in this field are continually introducing better formulations and delivery methods.
- Increasing Adoption of Subcutaneous Administration:
The rising adoption of subcutaneous administration (SCIG) of immunoglobulins due to its convenience and effectiveness is bolstering the market growth. SCIG allows patients to self-administer treatments at home, which reduces the need for frequent hospital visits and provides flexibility in dosing schedules. This method improves patient quality of life and treatment adherence, as it is less invasive and can be managed independently. Increasing preferences for SCIG over traditional intravenous methods on account of its associated benefits, including reduced infusion times, fewer side effects, and the ability to maintain more stable blood levels of immunoglobulins, is impelling the market growth.
Immunoglobulin Market Report Segmentation:
By Product:
- IgG
- IgA
- IgM
- IgE
- IgD
IgG represents the largest segment as it plays a critical role in the immune response and defense against pathogens.
By Application:
- Hypogammaglobulinemia
- Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Immunodeficiency Disease
- Myasthenia Gravis
- Others
Immunodeficiency disease holds the biggest market share due to its essential role in immunoglobulin therapy.
By Mode of Delivery:
- Intravenous Mode of Delivery
- Subcutaneous Mode of Delivery
Intravenous mode of delivery accounts for the largest market share, driven by its rapid and efficient absorption.
Regional Insights:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
North America enjoys a leading position in the immunoglobulin market on account of the presence of robust healthcare infrastructure with state-of-the-art medical facilities and technologies.
Global Immunoglobulin Market Trends:
The growing demand for immunoglobulin among the geriatric population, as they are more susceptible to immunodeficiency and autoimmune conditions, is offering a favorable market outlook. This demographic shift leads to a higher prevalence of diseases, such as pelvic inflammatory disease (PID) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), among individuals, which necessitates regular and effective immunoglobulin treatments to manage their health.
Governing agencies of various countries are providing more approvals for new immunoglobulin products, facilitating quicker market entry. In addition, they are funding and supporting research and development (R&D) efforts, which is impelling the market growth.
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163
